Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Grant revenue	$ 0	$ 0	$ 0	$ 582
Operating expenses:
Research And Development Expenses	19,826	15,820	37,183	33,733
General and administrative	9,129	7,311	18,294	13,633
Total operating expenses	28,955	23,131	55,477	47,366
Loss from operations	(28,955)	(23,131)	(55,477)	(46,784)
Other income (expense):
Interest and other	2,458	495	4,419	615
Total other income	2,458	495	4,419	615
Net loss	(26,497)	(22,636)	(51,058)	(46,169)
Comprehensive loss:
Unrealized losses on available-for-sale debt securities	(3)	(275)	337	(275)
Comprehensive loss	$ (26,500)	$ (22,911)	$ (50,721)	$ (46,444)
Net loss per share, basic	$ (0.59)	$ (0.57)	$ (1.19)	$ (1.17)
Net loss per share, diluted	$ (0.59)	$ (0.57)	$ (1.19)	$ (1.17)
Weighted-average common shares outstanding, basic	44,770,820	39,594,028	43,042,461	39,524,408
Weighted-average common shares outstanding, diluted	44,770,820	39,594,028	43,042,461	39,524,408